ANTHRACYCLINE PHARMACOKINETICS - LIMITED SAMPLING MODEL FOR PLASMA-LEVEL MONITORING WITH SPECIAL REFERENCE TO EPIRUBICIN (FARMORUBICIN)

被引:25
作者
EKSBORG, S
机构
[1] Karolinska Pharmacy, Stockholm
关键词
Anthracyclines; Doxorubicin; Epirubicin; Pharmaco-kinetics; Plasma level monitoring;
D O I
10.3109/02841869009090011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A new prinicple for plasma level monitoring of the anthracy-clines doxorubicin and epirubicin is presented. The area under the plasma concentration time curve (AUC) is linearly correlated with the maximum plasma concentration of the drugs at the end of 2 and 4 hours' constant rate infusions. From this relationship it is possible to obtain accurate estimates of the AUC values of the drugs in the individual patients from plasma samples, withdrawn during the last 15 minutes prior to the completion of the infusions. The limited sampling model for drug monitoring of doxorubicin and epirubicin described here is robust and simple to use. It does not require a strict time control for the withdrawing of samples. Measured maximum plasma concentrations of epirubicin during 2 hours' constant rate infusions of 70mgm-2 to patients with lymphoma (median age: 46.5 years) were within the range 171-404ngml-1 (median value: 265ngml-1). ©1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:339 / 342
页数:4
相关论文
共 13 条
[1]  
BRENNER DE, 1987, PATHOL BIOL, V35, P31
[2]  
DEGREGORIO MW, 1982, CANCER TREAT REP, V66, P2085
[3]   DEPENDENCE OF THE CYTOSTATIC EFFECT OF ADRIAMYCIN ON DRUG CONCENTRATION AND EXPOSURE TIME INVITRO [J].
EICHHOLTZWIRTH, H .
BRITISH JOURNAL OF CANCER, 1980, 41 (06) :886-891
[4]  
EKSBORG S, 1988, MED ONCOL TUMOR PHAR, V5, P131
[5]   COMPARATIVE PHARMACOKINETIC STUDY OF ADRIAMYCIN AND 4'EPI-ADRIAMYCIN AFTER THEIR SIMULTANEOUS INTRAVENOUS ADMINISTRATION [J].
EKSBORG, S ;
STENDAHL, U ;
LONROTH, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (05) :629-631
[6]  
Eksborg S, 1984, J Pharm Biomed Anal, V2, P297, DOI 10.1016/0731-7085(84)80080-1
[7]   PHARMACOKINETIC STUDY OF IV-INFUSIONS OF ADRIAMYCIN [J].
EKSBORG, S ;
STRANDLER, HS ;
EDSMYR, F ;
NASLUND, I ;
TAHVANAINEN, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (02) :205-212
[8]  
EKSBORG S, 1985, MED ONCOL TUMOR PHAR, V2, P47
[9]  
PREISLER HD, 1984, CANCER CHEMOTH PHARM, V12, P125
[10]  
RATAIN MJ, 1989, P ASCO, V8, P7